Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for consciousness recovery in traumatic brain injury
IRCT20240415061495N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate in traumatic brain injury (TBI) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Glasgow Coma Scale score, APACHE II score and 4 more. Started Apr 2024; status: completed.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20240415061495N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240415061495N1.